Skip to main content
. Author manuscript; available in PMC: 2015 Oct 23.
Published in final edited form as: Pediatrics. 2013 Aug 12;132(3):e604–e611. doi: 10.1542/peds.2013-1002

Table 2.

Factors associated with late detection of critical congenital heart disease (CCHD) among Florida-born infants, 1998-2007

Characteristic Adjusted
prevalence ratioa
(95% confidence interval)
Maternal / household

Mother’s age, years
 ≤ 24 1.0 (0.9-1.2)
 25-34 Reference
 ≥35 1.0 (0.9-1.0)
Mother’s race / ethnicity
 White, non-Hispanic Reference
 Black, non-Hispanic 1.1 (0.9-1.2)
 Hispanic 1.0 (0.8-1.2)
 Asian / Pacific Islander and American Indian / Alaskan 1.3 (0.8-2.0)
Mother’s education
 Less than high school graduate 1.0 (0.8-1.2)
 High school graduate or equivalent 1.2 (1.0-1.4)
 College or university (some or graduate) Reference
Mother’s nativity: foreign-born 0.8 (0.7-1.0)
Principal healthcare payer type on birth hospitalization recordb
 Private Reference
 Public 1.0 (0.9-1.2)
 Self-Insured/Uninsured 1.2 (0.9-1.6)
Birth hospital nursery level
 I 1.9 (1.6-2.2)
 II 1.5 (1.3-1.7)
 III Reference

Infant

Sex, female 1.0 (0.9-1.1)
Preterm or very preterm birth (20-36 weeks) 0.9 (0.7-1.0)
Non-cardiac congenital anomaly 0.9 (0.8-1.1)
Plurality: multiple gestation 0.8 (0.5-1.3)
Critical congenital heart disease type (CCHD)c,d
Single condition
 Hypoplastic left heart syndrome (HLHS)d Reference
 Aortic interruption/atresia/hypoplasia (AI/A) 2.2 (1.4-3.4)
 Coarctation/hypoplasia of aortic arch (COA) 2.9 (2.1-4.0)
 Double-outlet right ventricle (DORV) 2.5 (1.7-3.8)
 Dextro-transposition of the great arteries (d-TGA)d 0.8 (0.5-1.2)
 Ebstein anomaly (EA) 0.8 (0.6-1.7)
 Pulmonary atresia (PA)d 1.7 (1.1-2.7)
 Single ventricle (SV) 2.2 (1.1-4.1)
 Truncus arteriosus (TA)d 2.5 (1.7-3.8)
 Total anomalous pulmonary venous connection (TAPVC)d 2.7 (1.8-4.0)
 Tetralogy of Fallot (TOF)d 1.9 (1.4-2.6)
 Tricuspid atresia (TRA)d 1.3 (0.8-2.1)
Year of birth
 1998 1.0 (0.8-1.4)
 1999 1.2 (0.9-1.6)
 2000 1.2 (1.0-1.6)
 2001 1.4 (1.1-1.8)
 2002 1.1 (0.8-1.4)
 2003 1.2 (0.9-1.5)
 2004 1.4 (1.1-1.8)
 2005 0.9 (0.7-1.2)
 2006 0.9 (0.7-1.1)
 2007 Reference

Bold results indicate p-value <0.05

a

Adjusted models controlled for all characteristics listed in the table. The results shown here are for the multivariable model which examined the effect of CCHD type for infants with a single CCHD, and therefore excludes infants with multiple CCHDs.

b

Private insurance included employer-based insurance (including Tricare). Public insurance included Medicare, Medicaid, Veteran’s Administration insurance, and other state and local government insurance in Florida, such as KidCare.

c

CCHD identified by ICD-9-CM codes: HLHS: 746.7, AI/A: 747.11, 747.22; COA: 747.10; DORV: 745.11; d-TGA: 745.10; EA: 746.2; PA: 746.01; SV: 745.3; TA: 745.0; TAPVC: 747.41; TOF: 745.2; TRA: 746.1.

d

Primary targets for pulse oximetry screening.1,14,15